176 related articles for article (PubMed ID: 21789693)
1. [The presymptomatic stage of neurodegenerative disorders].
Klein C; Hagenah J; Landwehrmeyer B; Münte T; Klockgether T
Nervenarzt; 2011 Aug; 82(8):994-1001. PubMed ID: 21789693
[TBL] [Abstract][Full Text] [Related]
2. ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.
Cozaru GC; Aşchie M; Mitroi AF; Poinăreanu I; Gorduza EV
Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):15-22. PubMed ID: 27125067
[TBL] [Abstract][Full Text] [Related]
3. Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases.
Liu CS; Cheng WL; Kuo SJ; Li JY; Soong BW; Wei YH
J Neurol Sci; 2008 Jan; 264(1-2):18-21. PubMed ID: 17720200
[TBL] [Abstract][Full Text] [Related]
4. [Predictive testing: presymptomatic diagnosis in neurogenetic disorders].
Dürr A; Gargiulo M; Feingold J
Med Sci (Paris); 2005 Nov; 21(11):934-9. PubMed ID: 16274644
[TBL] [Abstract][Full Text] [Related]
5. Huntington disease and Huntington disease-like in a case series from Brazil.
Castilhos RM; Souza AF; Furtado GV; Gheno TC; Silva AL; Vargas FR; Lima MA; Barsottini O; Pedroso JL; Godeiro C; Salarini D; Pereira ET; Lin K; Toralles MB; Saute JA; Rieder CR; Quintas M; Sequeiros J; Alonso I; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2014 Oct; 86(4):373-7. PubMed ID: 24102565
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic tests in Huntington's disease and dominant ataxias.
Cannella M; Simonelli M; D'Alessio C; Pierelli F; Ruggieri S; Squitieri F
Neurol Sci; 2001 Feb; 22(1):55-6. PubMed ID: 11487199
[TBL] [Abstract][Full Text] [Related]
7. PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Brockmann K; Reimold M; Globas C; Hauser TK; Walter U; Machulla HJ; Rolfs A; Schöls L
J Nucl Med; 2012 Jul; 53(7):1074-80. PubMed ID: 22653791
[TBL] [Abstract][Full Text] [Related]
8. Looking backward to move forward: early detection of neurodegenerative disorders.
DeKosky ST; Marek K
Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
[TBL] [Abstract][Full Text] [Related]
9. Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).
Stevanin G; Brice A
Cerebellum; 2008; 7(2):170-8. PubMed ID: 18418687
[TBL] [Abstract][Full Text] [Related]
10. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
[TBL] [Abstract][Full Text] [Related]
11. [Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers].
Wolf RC; Vasic N; Schönfeldt-Lecuona C; Ecker D; Landwehrmeyer GB
Nervenarzt; 2008 Apr; 79(4):408-20. PubMed ID: 18074113
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.
Shannon KM
Handb Clin Neurol; 2011; 100():3-13. PubMed ID: 21496568
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic analysis of 29 Brazilian patients with Huntington's disease-like phenotype.
Rodrigues GR; Walker RH; Bader B; Danek A; Brice A; Cazeneuve C; Russaouen O; Lopes-Cendes I; Marques W; Tumas V
Arq Neuropsiquiatr; 2011 Jun; 69(3):419-23. PubMed ID: 21755114
[TBL] [Abstract][Full Text] [Related]
15. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
16. [The advances in research on phosphorylation of polyglutamine disease].
Zhou YF; Jiang H; Tang JG; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
[TBL] [Abstract][Full Text] [Related]
17. miRNAs as biomarkers of neurodegenerative disorders.
Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
[TBL] [Abstract][Full Text] [Related]
18. Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders.
Wei TY; Fu Y; Chang KH; Lin KJ; Lu YJ; Cheng CM
Trends Biotechnol; 2018 Mar; 36(3):290-303. PubMed ID: 29242004
[TBL] [Abstract][Full Text] [Related]
19. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Dec; 50(6):373-80. PubMed ID: 11761463
[TBL] [Abstract][Full Text] [Related]
20. No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Schöls L; Reimold M; Seidel K; Globas C; Brockmann K; Hauser TK; Auburger G; Bürk K; den Dunnen W; Reischl G; Korf HW; Brunt ER; Rüb U
Brain; 2015 Nov; 138(Pt 11):3316-26. PubMed ID: 26362908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
